An Overview of siRNA Delivery Strategies for Urological Cancers

The treatment of urological cancers has been significantly improved in recent years. However, for the advanced stages of these cancers and/or for those developing resistance, novel therapeutic options need to be developed. Among the innovative strategies, the use of small interfering RNA (siRNA) see...

Descripción completa

Detalles Bibliográficos
Autores principales: Halib, Nadia, Pavan, Nicola, Trombetta, Carlo, Dapas, Barbara, Farra, Rossella, Scaggiante, Bruna, Grassi, Mario, Grassi, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030829/
https://www.ncbi.nlm.nih.gov/pubmed/35456552
http://dx.doi.org/10.3390/pharmaceutics14040718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030829/
https://www.ncbi.nlm.nih.gov/pubmed/35456552
http://dx.doi.org/10.3390/pharmaceutics14040718

Ejemplares similares